Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

This article explores how digital maturity in process design and parameter management can drive significant time and cost savings, streamline tech transfers and ultimately accelerate patient access to ...

A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...